RECALLS

Home > Recalls / Product alerts / Drug alerts

RECALL: Pabrinex intravenous high potency injection (15 August)

Link Pharmaceuticals is recalling the following batch of Pabrinex (ascorbic acid, anhydrous glucose, nicotinamide, pyridoxine, riboflavin, thiamine) intravenous high potency injection due to the presence of particulate contamination. Pabrinex is marketed as both an intravenous and intramuscular presentation, but the recall is limited to this single batch of the intravenous presentation. The cartons contain 10 pairs of ampoules. The individual ampoules are batch number 028 but the carton batch number is 028725. This batch was first distributed on 19 January.

Recipients are asked to quarantine any remaining stock and return it to their supplier for either credit or replacement stock. Medical enquiries and customer enquiries relating to stock returns on 01403 272451.

MHRA alert